Presently, the people living with hiv antiretroviral therapy coverage in Tajikistan stands at 63%, an increase of 1% (1.6%) since 2021.
People living with HIV antiretroviral therapy coverage in Tajikistan
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Tajikistan
Antiretroviral therapy coverage
More indicators for Tajikistan
Male unintentional poisoning
0.6
0.0
(2019)
Female wasting in children
5%
+1.5%
(2017)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar223
+intl dollar18
(2021)
Birth registration
95.8%
+14.1%
(2017)
Contraceptive modern method prevalence
27.1%
+1.3%
(2017)
Tajikistan Antiretroviral therapy coverage between 2000 and 2022
| Period | Antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 63% | +1% |
| 2021 | 62% | +1% |
| 2020 | 61% | +3% |
| 2019 | 58% | +3% |
| 2018 | 55% | +4% |
| 2017 | 51% | +5% |
| 2016 | 46% | +7% |
| 2015 | 39% | +8% |
| 2014 | 31% | +8% |
| 2013 | 23% | +3% |
| 2012 | 20% | +1% |
| 2011 | 19% | +3% |
| 2010 | 16% | +4% |
| 2009 | 12% | +4% |
| 2008 | 8% | +2% |
| 2007 | 6% | +1% |
| 2006 | 5% | +5% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |